Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/20/2009US20090209567 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
08/20/2009US20090209566 Spirocyclic Compounds
08/20/2009US20090209565 Therapeutic agent for inflammatory bowel disease
08/20/2009US20090209564 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
08/20/2009US20090209563 Pyridinoylpiperidines as 5-HT1F agonists
08/20/2009US20090209562 Fused ring 4-oxopyrimidine derivative
08/20/2009US20090209561 Xanthine Derivatives with HM74A Receptor Activity
08/20/2009US20090209560 Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3
08/20/2009US20090209559 Pharmaceutical compounds
08/20/2009US20090209558 Polymer formulations for delivery of bioactive materials
08/20/2009US20090209557 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
08/20/2009US20090209556 Soluble guanylate cyclase activators
08/20/2009US20090209555 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
08/20/2009US20090209554 Thiazoliums as transketolase inhibitors
08/20/2009US20090209553 Arylpiperazine derivatives and uses thereof
08/20/2009US20090209552 Organic Compounds
08/20/2009US20090209551 Essential tremor diagnostic and treatment
08/20/2009US20090209550 Substituted triazolopyridines
08/20/2009US20090209549 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
08/20/2009US20090209548 Formulation for stimulating hair growth
08/20/2009US20090209547 C-8 halogenated macrolides
08/20/2009US20090209546 L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine
08/20/2009US20090209545 Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine
08/20/2009US20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
08/20/2009US20090209543 Folates, compositions and uses thereof
08/20/2009US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
08/20/2009US20090209541 Aprepitant compositions
08/20/2009US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same
08/20/2009US20090209539 Pyrimidine derivatives as alk-5 Inhibitors
08/20/2009US20090209538 Therapeutic substituted lactams
08/20/2009US20090209537 Aurora inhibitors
08/20/2009US20090209536 Aminoquinazoline cannabinoid receptor modulators for treatment of disease
08/20/2009US20090209535 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
08/20/2009US20090209534 Novel compounds and use of tetrahydropyridopyridothiophenes
08/20/2009US20090209533 Aldh-2 inhibitors in the treatment of addiction
08/20/2009US20090209532 Pharmaceutical compounds
08/20/2009US20090209531 used for treating metabolic, nervous sytsem and skin disorders,inflammatory diseases, obesity, cachexia, erectile dysfunction, neuropathic pain, or as antidepressants, anxiolytic and anticarcinogenic agents
08/20/2009US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/20/2009US20090209529 4,5-dihydro-oxazol-2-yl amine derivatives
08/20/2009US20090209528 Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments
08/20/2009US20090209527 Methods for Using Rapamycin Analogues in the Treatment of Neurological Disorders
08/20/2009US20090209526 Inhibitors of protein aggregation
08/20/2009US20090209525 Enabling methods to identify allosteric modulators of receptor activity
08/20/2009US20090209524 Novel Compounds
08/20/2009US20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
08/20/2009US20090209522 Heterocyclic Non-Peptide GNRH Antagonists
08/20/2009US20090209521 Inhibition of VEGF Translation
08/20/2009US20090209520 2 -oxybenzamide derivatives as parp inhibitors
08/20/2009US20090209517 Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders
08/20/2009US20090209516 9-amino-acridine derivatives and method of treating autoimmune diseases using the same
08/20/2009US20090209515 Association of a sinus node if current inhibitor and a Beta Blocker
08/20/2009US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists
08/20/2009US20090209512 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
08/20/2009US20090209511 Benzofuran Derivatives
08/20/2009US20090209510 Novel Method of Treating Hyperlipidemia
08/20/2009US20090209509 Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer
08/20/2009US20090209508 Compounds for Photochemotherapy
08/20/2009US20090209507 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies
08/20/2009US20090209506 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes
08/20/2009US20090209505 Prodrugs of heteroaryl compounds
08/20/2009US20090209504 Use of Digitalis-Like Compounds in the Treatment of Affective Disorders
08/20/2009US20090209503 Colonic delivery therapeutic agents for inflammatory bowel disease
08/20/2009US20090209502 Compositions of glycopyrronium salt for inhalation
08/20/2009US20090209501 Method of treating and preventing secondary hyperparathyroidism
08/20/2009US20090209500 Use of vitamin d receptor agonists and precursors to treat fibrosis
08/20/2009US20090209499 Apiary veterinary composition
08/20/2009US20090209498 Methods of Treatment Using CCA1 Inhibitors
08/20/2009US20090209497 Method of treating lymphangioleiomyomatosis (lam)
08/20/2009US20090209496 Methods and compositions for enhancing the efficacy of rtk inhibitors
08/20/2009US20090209495 Use of edg receptor binding agents in cancer
08/20/2009US20090209494 21-deoxymacbecin analogues useful as antitumor agents
08/20/2009US20090209493 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
08/20/2009US20090209492 Lipase Inhibitors
08/20/2009US20090209491 Lactams as conformationally constrained peptidomimetic inhibitors
08/20/2009US20090209489 Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
08/20/2009US20090209488 Compositions for the treatment of exercise induced asthma
08/20/2009US20090209487 Compositions of carbohydrates as dietary supplements
08/20/2009US20090209486 Nutraceuticals for defense against viral diseases, infections such as traveler's diarrhea, and gastrointestinal disorders; mannose, n-acetylneuraminic acid, fucose, n-acetylgalactosamine, xylose with one of glucosamine HCL, glucosamine sulfate, galactose, or flavorings, and also e.g. honey or olive oil
08/20/2009US20090209485 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides
08/20/2009US20090209484 Preventive and/or therapeutic agent for calcipenia
08/20/2009US20090209483 Treatments for flaviviridae virus infection
08/20/2009US20090209482 Azacytidine analogues and uses thereof
08/20/2009US20090209481 Nucleoside prodrugs and uses thereof
08/20/2009US20090209480 Central administration of stable formulations of therapeutic agents for cns conditions
08/20/2009US20090209479 Thiocarbon-protecting groups for rna synthesis
08/20/2009US20090209478 Compositions and methods for inhibiting expression of the hamp gene
08/20/2009US20090209477 Azacytidine analogues and uses thereof
08/20/2009US20090209475 Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same
08/20/2009US20090209474 Novel uses for drugs targeting glutamine synthetase
08/20/2009US20090209473 Componds and methods for pormoting angiogenesis
08/20/2009US20090209471 Abuse-resistant amphetamine prodrugs
08/20/2009US20090209465 MCT1 Transporters Expressed in Blood Brain Barrier Cells
08/20/2009US20090209462 Regulation of function of angiopoietin
08/20/2009US20090209461 Modification of feeding behavior
08/20/2009US20090209459 Method of Treating Myasthenia Gravis
08/20/2009US20090209456 Compositions and methods for improving facial and body aesthetics
08/20/2009US20090209452 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
08/20/2009US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
08/20/2009US20090209450 MicroRNA Fingerprints During Human Megakaryocytopoiesis
08/20/2009US20090209034 Tumour rejection antigens
1 ... 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 ... 7860